[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Fasenra- Drug Insight, 2019

July 2019 | 35 pages | ID: F918CD972B5EN
DelveInsight

US$ 1,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within 48 Hours

'Fasenra - Drug Insight, 2019' report by DelveInsight provides comprehensive information of the drug, Fasenra. It includes drugs overview, Fasenra mechanism of action, clinical trials, regulatory milestones, deals & Fasenra’s partnerships. It further provides Fasenra`s patents (US & EU)* and its API manufacturers details in the United States, Europe, China and India.* It also features the historical and forecasted Fasenra sales till 2021. The report also throws light on Fasenra market competition and emerging therapies in the same space as Fasenra. Fasenra SWOT analysis is also featured. * Depending on information availability

METHODOLOGY

Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts. Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

SCOPE OF THE REPORT
  • A comprehensive Fasenra overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
  • Fasenra Patent information in United States (US) and Europe (EU) has been highlighted
  • Fasenra API manufacturers in United States, Europe, China and India
  • The report contains historical and forecasted Fasenra sales till 2021
  • Comprehensive coverage of the emerging therapies (Phase III) in the space where Fasenra operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
  • The report also features the Fasenra SWOT analysis
REASONS TO BUY
  • Establish a comprehensive understanding of the drug, Fasenra
  • Access to Fasenra API manufacturers details to devise API procurement strategy for generic development
  • Plan developmental timelines around Fasenra patents for the major markets- US and EU
  • Understand current and future Fasenra`s growth through its historical and forecasted sales
  • Identify and understand the current in-market competitors for Fasenra
  • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
  • Identify and plan ahead for prospective emerging players and their products operating in the same space as Fasenra
  • Identify opportunities in the same area as with Fasenra SWOT analysis
1. REPORT INTRODUCTION

2. FASENRA - OVERVIEW

Fasenra Product Description
Fasenra Route of Synthesis
Fasenra Mechanism of Action
Fasenra Pharmacology
Fasenra Pharmacodynamics
Fasenra Pharmacokinetics
Fasenra Adverse Reactions
Fasenra Clinical Trials
Fasenra Regulatory Milestones
Fasenra Development Activities

3. GLOBAL API MANUFACTURERS

United States
Europe
China
India

4. PRODUCT DETAILS

United States
Europe

5. FASENRA GLOBAL SALES ASSESSMENT

Fasenra Sales Global(Historical)
Fasenra Sales Global(Forecasted)

6. FASENRA PATENT DETAILS

7. FASENRA MARKET COMPETITION

8. FASENRA EMERGING THERAPIES

8.1. Drug name: Company name
Product Description
Research & Development
Product Development Activities
Other product profiles in the detailed report

9. FASENRA SWOT ANALYSIS

Appendix
Methodology
Consulting Services
About DelveInsight

LIST OF TABLES

Table 1: Fasenra, Description
Table 2: API Manufacturers Region wise
Table 3: API Manufacturers for United States
Table 4: API Manufacturers for Europe
Table 5: API Manufacturers for China
Table 6: API Manufacturers for India
Table 7: Fasenra Product Details, United States
Table 8: Fasenra Product Details, Europe
Table 9: Fasenra, Historical Global Sales till 2017 (in million USD)
Table 10: Fasenra, Forecasted Global Sales from 2019-2021 (in million USD)
Table 11: Patent Details: Fasenra
Table 12: Fasenra Major Competitors
Table 13: Emerging Therapies

LIST OF FIGURES

Figure 1: Fasenra
Figure 2: Fasenra, Historical Global Sales till 2017 (in million USD)
Figure 3: Fasenra, Forecasted Global Sales from 2019-2021 (in million USD)
Figure 4: Patent Details: Fasenra
Figure 5: API Manufacturers Region wise


More Publications